Anti-CTLA-4/CD152 Antibody (Tremelimumab)
Catalog No.
F1373
Anti-CTLA-4/CD152 Antibody (Tremelimumab)
Featured Products
Tremelimumab (Ticilimumab) is a fully human monoclonal antibody specific for cytotoxic T lymphocyte antigen 4 (CTLA-4) for use in metastatic melanoma research.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146.38 kDa
Dry ice
745013-59-6
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
ticilimumab, CP-675206, clone 11.2.1
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P16410
Human, Cynomolgus
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human CTLA 4 His at 2 ug/mL can bind Anti-CTLA-4/CD152 Antibody (Tremelimumab)
CTLA-4 / CD152
Please avoid freeze-thaw cycles.